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Background: The innate immune response like phagocytosis, encapsulation and antimicrobial peptide (AMP)
production often occur in the early stage of host-pathogen interactions in Drosophila melanogaster. To investigate
the Drosophila early immune response to Drosophila C virus, we characterized the DCV infection-response
transcriptome of Drosophila Schneider 2 (S2) cells at one hour post inoculation.
Method: The total RNA was extracted from treated S2 cells by using Trizol reagent and then analyzed by CapitalBio
Corp for Drosophila GeneChip (Affymetrix) assay. Then the results of signaling pathway and protein interaction
about these genes were analyzed by MAS 3.0 software.
Results: Most significantly affected genes (656 genes) by DCV infection were regulated as the same way in
inactivated DCV treatment, but inactivated white spot syndrome virus (WSSV) showed a different transcriptome.
DCV infection up-regulated the expression levels of 275 genes and down-regulated that of 442 genes significantly
and some affected genes were related to phagocytosis. DCV infection activated the JAK/STAT pathway by 1 hour
post incubation. The Imd pathway was activated and transcriptional induction of antimicrobial peptides (AMPs)
from this pathway was enhanced by 1 hour post incubation. But the Toll pathway was not activated like Imd
pathway and the expression levels of AMPs from this pathway was reduced. In addition, most pattern-recognition
receptors were inhibited and the antiviral RNAi pathway was not activated in the early stage of DCV infection.
Conclusions: In conclusion, the present study demonstrates that DCV infection may activate phagocytosis, JAK/STAT
pathway and Imd pathway in the early host-virus interactions. These results indicate that DCV is capable of activating or
inhibiting some immune responses in the host cells and these changes would be vital for virus entry and replication.
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The innate immune response of Drosophila is governed
by numerous signaling pathways that trigger antimicro-
bial peptide (AMP) production, phagocytosis, melani-
zation, and encapsulation to limit infection after
exposure to microbes [1,2]. Drosophila C virus (DCV)
is a non-occluded isometric virus which containing a
positive sense RNA genome [3,4]. DCV is a natural
pathogen of the model organism D. melanogaster, mak-
ing it an ideal model system for studying invertebrate
host-virus interactions [5]. The mechanisms of antiviral
defense in Drosophila highlight the potential of the D.
melanogaster model for studying antiviral innate* Correspondence: zhufei@zju.edu.cn
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reproduction in any medium, provided the orimmunity [6]. It is found that the Imd pathway is in-
volved in the antiviral immune responses of Drosophila
[7,8]. The Toll pathway is required for efficient inhib-
ition of Drosophila X virus replication in Drosophila
and constitutive activation of the pathway resulted in
decreased viral titer [9]. Recently RNA interference
(RNAi) was found to mediate innate antiviral immunity
in Drosophila [10-12]. The JAK/STAT signaling path-
way is reported to involve in the antiviral response of
Drosophila [11-13]. However, many viruses always
develop the ability of suppressing or evading host
immune response. No evidence for the activation of
the Toll, IMD or JAK/STAT pathways was found in
D. melanogaster infected with the sigma virus
(Rhabdoviridae) [14]. And dengue virus (DENV) may
suppress immune responses at early infection stages. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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aegypti [15]. So it is very necessary to study the early
immune response to pathogenic virus in host cells.
White spot syndrome virus (WSSV) is a bacilliform,
enveloped double stranded DNA virus that causes viral
diseases in shrimp [16]. To investigate early immune
responses against DCV, we exposed Drosophila S2 cells
to DCV, inactivated DCV (inDCV), and inactivated
WSSV (inWSSV). We selected inWSSV as a treatment
but not WSSV because WSSV was not phagocytosed
by S2 cells like DCV and inDCV and induced very
complicated early response. We investigated the tran-
scriptional profile of virus-challenged Drosophila S2
cells using oligonucleotide DNA microarrays to iden-
tify the Drosophila early immune response to DCV.
This results of this study contribute to the understand-
ing of early immunologic defense responses in inverte-
brate hosts to viral challenge, and this study paves the
way for further experiments which investigate the roles
of genes and pathways in antiviral immunity.Results and discussion
Genome-wide analysis of the Drosophila early immune
response to DCV
We investigate Drosophila S2 cells in early immune re-
sponse to DCV to systematically dissect host functions im-
portant in responding to virus. Genome-wide analysis can
be conducted easily in genetically tractable model hosts,
such as D. melanogaster, and such analyses offer a new ap-
proach to identifying host genes required for host antiviral
immunity. We conducted a genome-wide analysis of the
Drosophila early immune response to DCV by using oligo-
nucleotide microarrays. Our results show that DCV infec-
tion significantly up-regulated the expression levels of
275 genes and significantly down-regulated that of 442
genes at least 2-fold (Table 1). Some of these genes function
as immunity signal transduction, antimicrobial peptides,
pattern-recognition receptors and apoptosis (Table 2). Most
of these affected genes (656 genes) were regulated com-
monly in DCV and inDCV treatment (Figure 1A). In the
656 affected genes, the most highly up-regulated 5 genes
were Pherokine 3 (>50 fold, function as protein serine/
threonine kinase activity), shaven baby (>28 fold, function as
sequence-specific DNA binding), Matrix metalloproteinase
1 (>23 fold, function as metalloendopeptidase activity), Ribo-
somal protein S5b (>13 fold, function as RNA binding) and
CG34330 (>13 fold, function as neurogenesis). And the
most strongly down-regulated 5 genes were Hemese (>50
fold, function as negative regulation of lamellocyte differenti-
ation), CG34003 (>30 fold, function as bacterial cell surface
binding), nimrod C1 (>29 fold, function as defense response
to bacterium), Projectin (>24 fold, function as structural
constituent of cytoskeleton) and CG9616 (>21 fold). Inaddition, 178 genes were regulated commonly in DCV,
inDCV and inWSSV treatments. The functional analysis
shows that the 178 genes participated in diverse biological
processes including transport, cellular metabolism, cytoskel-
eton regulation, chemosensory reception, diverse functions
and so on (Figure 1B). In addition, 57 genes were signifi-
cantly affected in Drosophila S2 cells at 1 hour
post inoculation in cells infected with DCV but not in the
other two treatments (Figure 1A). A total of 24 genes were
up-regulated and 33 genes were down-regulated signifi-
cantly (P<0.05). Gene ontology and KEGG analyses
revealed that most of these genes were related
to cellular metabolism. The similar result was found
in Aedes aegypti cells with dengue virus infection
[17]. Among the 57 genes, βTub97EF, DNApol-α50,
Cyp9f2, and Csk were not directly related to cellular
metabolism (Figure 1C). βTub97EF has GTPase activity
and contributes to microtubule-based movement and
phagosome conserved biosystem, and it is linked with
CG31048 which participate in activation of Rac GTPase
activity. DNApol-α50 has DNA polymerase activity and
contributes to DNA replication and synthesis of RNA pri-
mer, and it is linked with Pde8 (3',5'-cyclic-AMP phospho-
diesterase activity), Mcm6 (contributes to 3'-5' DNA
helicase activity), argos (receptor antagonist activity) and
mew (cell adhesion molecule binding). Cyp9f2 is an age-
regulated gene which anticipates in oxidation-reduction
process, and it is linked with CG4389 (enoyl-CoA hydratase
activity), CG4598 (dodecenoyl-CoA delta-isomerase activ-
ity) and CG15739 (4-nitrophenylphosphatase activity) [18].
βTub97EF, Cyp9f2 and DNApol-α50 were down-regulated
very significantly (P<0.01) in DCV treatment but not in the
other two treatments. C-terminal Src kinase (Csk) is the
major inhibitor of Src signaling, and it is linked with
CG6410 (phosphatidylinositol binding), CG10479 (un-
known function) and Cad96Ca (protein tyrosine kinase ac-
tivity). In this study, Csk was up-regulated very significantly
(P<0.01) in DCV treatment but not in the other two treat-
ments. Csk functions with Src-family kinases to negative
regulate cell proliferation and positive regulate apoptosis
[19-24]. Endocytosis or phagocytosis is the key step in the
interaction between virus and host cells, and virus could
utilize them to entry and infect host cells [25,26]. So these
genes induced by DCV infection may involved in phagocyt-
osis of host cells in 1 hour post inoculation.
JAK/STAT pathway is involved in antiviral immunity in
Drosophila
As a reporter of Drosophila responsible for DCV infection,
virus-induced RNA 1 (vir-1) is one of genes resulting from
JAK/STAT signaling pathway which is not induced by
pathogenic bacteria or fungi [13,27]. Expression of Vir-1
was not modified by many stresses, such as heat shock,
cold shock, mechanical pressure, dehydration or ultraviolet
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tions in the antiviral immune response of Drosophila [5].
The results of this study showed that Vir-1 was signifi-
cantly up-regulated (P<0.01) in all three treatments,
suggesting the involvement of JAK/STAT pathway in anti-
viral responses of Drosophila (Figure 2). Furthermore, Vir-
1 was significantly up-regulated (P<0.01) in response to
WSSV (a non-pathogenic virus of Drosophila) as it was in




275 up-regulated genes 18w, a, Ald, alpha-Adaptin, alpha-Est1, alphaP
AttC, AttD, b, B52, Best1, bnl, brp, bves, CaMK
CG10630, CG10641, CG10657, CG10702, CG10
CG11825, CG11897, CG12014, CG12054, CG12
CG13196, CG13248, CG13335, CG1340, CG134
CG14801, CG14879, CG15097, CG15308, CG15
CG17660, CG17681, CG18528, CG18557, CG18
CG30502, CG31012, CG31323, CG31324, CG31
CG32170, CG32206, CG32207, CG32313, CG32
CG34383, CG34404, CG3788, CG3884, CG4232
CG5346, CG5535, CG5758, CG5919, CG6051, C
CG7510, CG7720, CG7778, CG7794, CG7816, C
CG9312, CG9626, CG9641, CG9663, CG9812, C
Dhap-at, drl, Ets21C, ewg, fra, Gadd45, GlcAT-
ImpL2, ImpL3, insc, inx2, Irk3, jar, JhI-21, Jupit
Mf, Mmp1, moody, Mpk2, mthl2, Mtk, MtnA,
Obp44a, Or19a, ovo, Pabp2, pain, Pak, path, P
Rgn, RhoGEF3, RhoL, RN-tre, rogdi, RpS5b, rtG
tamo, Thor, tmod, Tom34, Trc8, Tsp, Tsp42Eg
yellow-b, zfh1, zpg
442 down-regulated genes Ac13E, Ac76E, Acer, Acox57D-d, Act79B, Adk3
bgm, bmm, bt, by, Cad96Ca, CG10026, CG100
CG10469, CG10479, CG10512, CG10550, CG10
CG11319, CG11347, CG11395, CG11400, CG11
CG12340, CG12512, CG12702, CG12744, CG12
CG13641, CG13654, CG13707, CG13794, CG13
CG14225, CG14511, CG14615, CG14619, CG14
CG14933, CG14990, CG1503, CG15043, CG151
CG15917, CG1607, CG1623, CG1628, CG1637,
CG17029, CG17032, CG17167, CG17270, CG17
CG18446, CG18522, CG18549, CG18563, CG18
CG30085, CG30090, CG30104, CG30148, CG30
CG30460, CG30463, CG30479, CG30492, CG31
CG31477, CG31601, CG31607, CG31674, CG31
CG32091, CG3224, CG32306, CG32320, CG323
CG32812, CG33225, CG33252, CG33275, CG33
CG3831, CG3857, CG3902, CG40160, CG4019,
CG42394, CG4250, CG42611, CG4325, CG4351
CG4928, CG4949, CG5080, CG5167, CG5191, C
CG5955, CG5958, CG5973, CG6045, CG6188, C
CG6812, CG6836, CG6951, CG7059, CG7083, C
CG7458, CG7607, CG7777, CG7781, CG7966, C
CG8211, CG8213, CG8353, CG8398, CG8399, C
CG9232, CG9331, CG9338 , CG9416, CG9463,
cpo, Cpr49Ac, Cpr65Au, Cpr97Eb, CPTI, CREG,
Cyp4s3, Cyp6a13, Cyp6a14, Cyp6a21, Cyp9f2,
eater, edl, egr, Ela, fan, fbp, fng, fru, fz2, GLaz,
htl, if, ine, Invadolysin, inx3, Irp-1B, Jheh3, Kap
mav, mbc, Mcm6, mew, mex1, mspo, Myd88
nimB5, nimC1, nimC2, Oat, Oatp33Ea, Obp18
PNUTS, prc, Prestin, Pxn, pyd, pyd3, qtc, r-cup
snk, Sp212, sqz, Sr-CI, Sry-alpha, stnA, Strn-Mlc
Tsp5D, TwdlE, twi, Ubc84D, Ugt35a, Ugt36Bc,Socs36E and Stam were up-regulated very significantly
(P<0.01), and TepI was down-regulated very significantly
(P<0.01) in pathogenic virus treatments (DCV and inDCV)
but not in non-pathogenic virus treatment (inWSSV)
(Figure 2). According to our data in this study, upd2,
Socs36E, Stam and TepI have special antiviral immunity to
pathogenic virus like DCV. But upd3 and vir-1 were up-
regulated significantly (P<0.01) in all three treatments (Fig-
ure 2). The cytokine unpaired 3 (upd3) has been previouslyS4, alphaPS5, AnnIX, alphaTub84D, aPKC, Asator, Ast, Atpalpha, AttA,
II, Ccn, Cct1, Cdk5, CecB, CecC, CG10011, CG10103, CG10337, CG10581,
962, CG1124, CG11353, CG11671, CG11779, CG11790, CG11791,
112, CG12290, CG12418, CG12477, CG12883, CG12896, CG13078,
82, CG14015, CG14085, CG14322, CG14340, CG14545, CG14567,
543, CG15673, CG1600, CG16717, CG16718, CG16833, CG17599,
643, CG18769, CG30108, CG30115, CG30281, CG30421, CG30466,
431, CG31522, CG31523, CG3168, CG31778, CG32048, CG32066,
512, CG32982, CG33099, CG3348, CG34330, CG34349, CG34360,
7, CG42348, CG4455, CG4570, CG4629, CG4726, CG5174, CG5246,
G6125, CG6231, CG6330, CG6357, CG6498, CG6767, CG7056, CG7251,
G7841, CG7888, CG8008, CG8046, CG8177, CG9119, CG9222, CG9238,
G9932, cher, chn, chrb, Cortactin, Cpr67Fa1, Csk, Cyp4g1, DAAM, dally,
S, Gli, Gp150, Gr94a, gsb, h, Hip1, Hsp22, Hsp70Aa, Hsp70Ba, Hsp70Bc, ifc,
er, kay, kel, KP78b, KrT95D, lcs, Lerp, Lis-1, Lmpt, loco, LpR2, Luna, Mctp,
Myo28B1, Myo31DF, mys, nahoda, nau, nes, Nhe3, nkd, Nrt, Oatp30B,
de8, Phk-3, pirk, Pka-C3, PKD, pot, ppk10, Prx2540-2, puc, Pvf2, Rel, Rep,
EF, scarface, sdk, shn, SIP3, slgA, Socs36E, Sox14, spir, Stam, stv, Su(dx),
, tty, Ugt36Bb, upd2, upd3, vfl, viaf, vir-1, Vrp1, WASp, wun, wun2,
, Amph, Ance-5, arg, armi, Atet, att-ORFA, aub, Bc, Best4, betaTub97EF,
73, CG10126, CG10131, CG10184, CG10205, CG10249, CG10336,
660, CG10764, CG10863, CG11063, CG11134, CG11147, CG11151,
638, CG11668, CG11686, CG11739, CG11943, CG12140, CG12262,
825, CG12970, CG13085, CG13116, CG13377, CG13559, CG13631,
822, CG13877, CG13897, CG14033, CG14141, CG14215, CG14216,
629, CG14741, CG14787, CG14803, CG14806, CG14856, CG14872,
61, CG15202, CG15333, CG15658, CG15739, CG15818, CG15820,
CG1648, CG16700, CG16712, CG16713, CG1674, CG16947, CG1702,
322, CG17323, CG17350, CG17549, CG17597, CG17839, CG17928,
622, CG2003, CG2052, CG2444, Cg25C, CG2893, CG30017, CG30069,
217, CG30269, CG30273, CG30345, CG30359, CG3036, CG30377,
048, CG31075, CG31145, CG31274, CG31313, CG31326, CG31454,
675, CG3184, CG31886, CG3191, CG31974, CG31999, CG32017, CG32085,
54, CG32364, CG3246, CG32582, CG3259, CG32613, CG32647, CG32700,
465, CG3402, CG34331, CG34398, CG34436, CG3505, CG3635, CG3829,
CG40244, CG41265, CG42259, CG42296, CG42345, CG42358, CG42369,
, CG4389, CG4398, CG4484, CG4576, CG4598, CG4615, CG4666, CG4733,
G5322, CG5381, CG5397, CG5455, CG5707, CG5731, CG5853, CG5895,
G6199, CG6208, CG6232, CG6289, CG6410, CG6426, CG6639, CG6687,
G7091, CG7120, CG7149, CG7255, CG7280, CG7320, CG7322, CG7358,
G7985, CG7995, CG7997, CG8066, CG8080, CG8097, CG8112, CG8157,
G8451, CG8501, CG8586, CG8668, CG8788, CG9008, CG9098, CG9117,
CG9505, CG9541, CG9577, CG9616, CG9624, CG9691, CG9973, CG9989,
Cyp12c1, Cyp12d1-d, Cyp18a1, Cyp28a5, Cyp28d1, Cyp4ac1, Cyp4d2,
Cyp9h1, Cys, Dh, dj-1beta, DNApol-alpha50, DNaseII, dpp, dpr17, drpr,
glob1, Glt, grh, GstD4, GstD5, GstD6, GstD7, He, Hil, hoe1, Hr51, Hsp60B,
-alpha3, l(3)neo38, lectin-24A, lectin-28C, lin-28, Lip4, Lkr, lox, mAcR-60C,
, MYPT-75D, nAcRalpha-30D, Nep4, NetB, Nha2, nimB2, nimB3, nimB4,
a, Obp99a, Obp99c, obst-A, olf186-M, out, Pde6, Pdk, PGRP-LE, Pka-R2,
, rdgB, rg, Rgk1, Rph, Rpt3R, ry, scpr-A, scu, shf, Sip1, Sk1, skpB, sls, sn,
k, su(r), Sucb, Sur, sut1, Taf12L, TepI, topi, TotA, troll, Tsp29Fa, Tsp2A,
Ugt86Dd, Vago, veil, vkg, W, wnd, y, yellow-f2, yellow-h, yip2
Table 2 Expression profiles of selected important
immune genes revolved in early immune response to
DCV, inDCV and inWSSV
Gene (GenBank accession number) DCV inDCV inWSSV
pattern-recognition receptors
PGRP-LE (AAF48519) 0.41 0.41 1.23
PGRP-LB (AAF54643) 1.51 1.16 2.71
PGRP-LF (AAF50301) 1.82 1.65 2.14
PGRP-SB1 (AAF49420) 1.81 1.64 2.09
Sr-CI (AAF51042) 0.15 0.13 1.22
Sr-CIII (AAN11166) 0.49 0.51 1.36
Eater (AAF56664) 0.32 0.32 0.65
TepI (AAF53490) 0.22 0.21 1.07
Lkr (AAF50775) 0.19 0.22 0.25
NimB2 (AAN10861) 0.12 0.10 0.29
NimB3 (ABC65899) 0.03 0.03 0.12
NimB4 (AAF53361) 0.12 0.10 0.33
NimB5 (AAF53363) 0.07 0.09 0.32
NimC1 (AAF53364) 0.03 0.03 0.10
NimC2 (AAF53366) 0.41 0.34 0.33
Antimicrobial peptides/protein
Attacin-A (AAF58215) 2.78 2.32 2.51
Attacin-C (AAM68570) 5.37 4.87 7.00
Attacin-D (AAF55446) 5.41 5.08 5.48
Andropin (AAF57024) 1.59 1.73 0.75
Cecropin (AAF57025) 7.94 8.14 1.28
Cecropin-B (AAF57027) 9.55 9.48 12.24
Drosomycin (AAF47767) 0.52 0.50 2.14
Drosocin (AAF58216) 1.29 1.24 2.19
Defensin (AAF58855) 0.53 0.43 0.84
Metchnikowin (AAF58139) 2.97 2.79 2.68
lectin24A (AAF51070) 0.39 0.49 0.87
lectin28C (AAF52570) 0.44 0.45 0.76
Immunity signal transduction
bnl (AAF55701) 2.50 2.92 0.45
Daam (AAF45600) 2.15 2.07 2.23
Dally (AAF50358) 2.41 2.24 2.22
bt (AAF55701) 0.04 0.04 0.07
mspo (AAF58219) 0.06 0.06 1.07
yellow-h (AAF59358) 0.07 0.08 0.16
prc (AAF49980) 0.05 0.06 0.36
Bc (AAF53744) 0.06 0.06 0.85
TotA (AAN13840) 0.07 0.06 0.38
Fz2 (AAF49184) 0.43 1.04 0.41
Myd88 (AAF58953) 0.39 0.39 1.16
Hsp60B (AAF51467) 0.47 0.41 1.94
Table 2 Expression profiles of selected important
immune genes revolved in early immune response to
DCV, inDCV and inWSSV (Continued)
Hsp70Aa (AAN13535) 2.72 4.55 0.64
Hsp70Bc (AAG22149) 2.43 5.04 0.88
Rel (AAF54333) 4.65 4.61 4.03
Mpk2 (AAF56244) 2.36 2.32 2.24
Rgk1 (AAF57577) 0.26 0.33 0.37
Mav (AAF59328) 0.33 0.30 0.48
upd3 (AAX52505) 2.70 3.07 4.33
upd2 (AAF48815) 5.23 6.42 1.74
Vago (AAF47993) 0.26 0.21 0.37
Vir-1 (AAF53185) 8.70 8.92 5.81
Vrp1 (AAF46800) 6.72 7.31 2.49
Ets21C (AAF51484) 3.38 4.03 3.58
dpr17 (AAF54750) 0.10 0.10 0.27
He (AAN10862) 0.02 0.02 0.18
Moody (AAF45709) 2.48 2.51 2.04
Pirk (AAF46746) 10.89 10.62 10.70
CG33275 (AAS65060) 0.07 0.08 0.39
CG9098 (AAF52322) 0.14 0.14 0.32
CG32354 (AAF50418) 0.27 0.30 2.55
CG4019 (AAF47036) 0.12 0.11 0.49
Apoptosis
AnnIX (AAF55841) 2.54 2.45 2.04
Sk1 (AAF48045) 0.28 0.26 0.44
Stv (AAF49809) 3.79 3.74 2.54
Viaf (AAF49974) 2.66 2.67 2.28
W (AAF49270) 0.22 0.21 0.34
Out (AAF48949) 0.43 0.37 0.44
CG3829 (AAF47310) 0.31 0.29 0.46
The gene expression levels were compared with that of control (S2 cells
without any treatment). The control’s was designated as 1.
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cytes [28,29]. The data indicate that upd3 and vir-1 be-
long to the common antiviral immunity in Drosophila.
A previous study showed that Drosophila did not mount
an immune response controlled by known immune
pathways against the sigma virus [14]. However, we
found that the JAK/STAT pathway was activated by
DCV infection at 1 hour post incubation.Toll pathway is involved in early response to Drosophila
C virus
Previously, it was shown that the Drosophila X virus
(DXV) activates the Toll pathway, and flies that are
Figure 1 Genome-wide analysis of the Drosophila early immune response to DCV. (A) Venn diagrams of genes that changed expression in
DCV, inDCV and inWSSV treatments. (B) Functional classification of 178 significantly regulated genes in DCV, inDCV and inWSSV treatments.
Functional group abbreviations are as follows: UNK, unknown functions; TRP, transport; MET, metabolism; CS, cytoskeletal and structural; CSR,
chemosensory reception; DIV, diverse functions; RTT, replication, transcription, and translation; PROT, proteolysis; DIG, blood and sugar food
digestive; RSM, redox, stress and mitochondrion; IMM, immunity. (C) The pathway gene correlation of the 57 genes according to KEGG databases.
Figure 2 Hierarchical cluster analysis of DNA microarray data
obtained from 21 genes in JAK/STAT pathway.
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are more susceptible to DXV infection [9]. Another
study showed that Dif deficient flies exhibit the same sen-
sitivity to DCV infection as wild-type flies [30]. In this
study, DCV infection down-regulated the expression levels
of Dif at one hour post infection. In Toll pathway, MyD88
and eater were down-regulated significantly (P<0.01), and
Mkk4, ndl, 18w, Toll-8 and Pli were up-regulated signifi-
cantly (P<0.01) in pathogenic virus treatments (DCV
and inDCV) but not in non-pathogenic virus treatment
(inWSSV) (Figure 3). The data indicate that these genes
have special immunity to pathogenic virus like DCV.
Interestingly, Drs (Drosomycin) was down-regulated sig-
nificantly (P<0.01) in pathogenic virus treatments (DCV
and inDCV) but was up-regulated significantly (P<0.01) in
non-pathogenic virus treatment (inWSSV). Drosomycin
(Drs) gene encodes a 44-residue inducible antifungal pep-
tide, Drosomycin, in Drosophila melanogaster [31]. Be-
cause the Toll pathway is so important for antiviral
immunity of Drosophila, DCV may inhibit the key factors
of this pathway to evade humoral and cellular responses of
host cells.
Figure 3 Hierarchical cluster analysis of DNA microarray data
obtained from 45 genes in Toll pathway.
Figure 4 Hierarchical cluster analysis of DNA microarray data
obtained from 17 genes in Imd pathway.
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C virus
In the Imd pathway, Rel, pirk and PGRP-LF were up-
regulated very significantly (P<0.01) in all three treat-
ments (Figure 4). PGRP-LE and PGRP-LC, PGRP family
member, are required for activation of the Imd pathway
in response to Gram-negative bacterial infections [32].
In this study, PGRP-LE was down-regulated very signifi-
cantly (P<0.01), and PGRP-LC was down-regulated in
pathogenic virus treatments (DCV and inDCV) but not
in non-pathogenic virus treatment (inWSSV) (Table 2).
The NF-κB-like transcription factor Relish is the ultim-
ate target of the Imd pathway, which regulates the ex-
pression of a battery of genes encoding antimicrobial
peptides (AMPs)-like Attacins [33,34]. AMP genes havebeen shown to be induced in response to viral infection
at levels similar to those observed during E. coli infec-
tion [9]. In this study, Attacin-A, Attacin-C, Attacin-D,
Cecropin-B and Metchnikowin were very significantly
up-regulated (P<0.01) in all three treatments (Table 2).
The results suggested that the Imd pathway was acti-
vated in DCV treatment and that the Imd pathway may
be involved in the antiviral immunity in Drosophila.
However, enhanced expression of single AMPs did not
alter resistance to viral infection or viral titer levels,
suggesting that the main antiviral response is cellular
rather than humoral [9]. DENV infection also down-
regulated the expression levels of numerous immune sig-
naling molecules and AMPs in Aedes aegypti cells [15,17].
In this study, Drosomycin, Defensin, lectin24A and
lectin28C were down-regulated very significantly (P<0.01)
in pathogenic virus treatments (DCV and inDCV) but not
in non-pathogenic virus treatment (inWSSV) (Table 2).
The data revealed that Drosomycin, Defensin, lectin24A
and lectin28C may play more important role in antiviral
immunity than other AMPs.
RNAi pathway was not activated in early response to
Drosophila C virus
Previous studies have shown that RNA interference played
a critical role in the control of viral infections in Drosoph-
ila and Ago2, Ars2, Dcr-2 and R2D2 as the core antiviral
RNAi machinery [10,35,36]. However, the relative expres-
sion of Ago1, Ago2, Ars2, Dcr-1, Dcr-2, R2D2 and Drosha,
which are important to antiviral RNAi pathway in Dros-
ophila, remained stable in all three experimental groups
(data not shown). The antiviral RNAi pathway was not ac-
tivated in S2 cells by 1 hour post incubation with DCV or
inWSSV. Virus infection in Drosophila initiates a specific
transcriptional response, including the induction of Vago,
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restrict viral replication in flies [37]. In this study, Vago was
significantly down-regulated (P<0.01) in all three treat-
ments (Table 2). The data indicate that the antiviral RNAi
pathway was not induced in S2 cells at 1 hour post incuba-
tion with DCV or inWSSV. Previous studies also showed
that DCV encodes a dsRNA-binding protein, DCV-1A,
which suppresses RNA silencing in Drosophila [38,39].
In Drosophila, invading pathogens can encounter
humoral and cellular responses that utilize pattern-
recognition receptors to identify pathogen-associated
molecular patterns on the immune cell surface [1,2]. In
this study, PGRP-LE, Sr-CI, Sr-CIII, Eater, TepI were
down-regulated significantly (P<0.01) in pathogenic
virus treatments (DCV and inDCV) but not in non-
pathogenic virus treatment (inWSSV) (Table 2). And
Lkr, NimB2, NimB3, NimB4, NimB5, NimC1, NimC2
were down-regulated significantly (P<0.01) in all three
treatments (Table 2). The results indicate that DCV
may escape the recognition of host immunity by inhib-
ition of pattern-recognition receptors on S2 cell surface
in the early stage of infection. Phagocytosis is the early
initiated innate immunity in Drosophila cells, so it is very
important for antiviral immunity [40,41]. DCV infection
may activate or utilize phagocytosis immunity of host cells
by 1 hour post inoculation because phagocytosis related
genes (Csk and βTub97EF) were up-regulated significantly
(P<0.01) by DCV infection only. TEM results also showed
that no difference was found in DCV-infected S2 cells at
one hour post infection, but DCV infection caused large
harm to S2 cells at one day post infection (Figure 5). DCV
infection activated the JAK/STAT pathway and the Imd
pathway in the early host-virus interaction. But the TollFigure 5 Transmission electron microscopy (TEM) of DCV-infected S2
hour post infection, Bar=1 μm. (C) DCV-infected S2 cells at one day post in
post infection, Bar=1 μm. The arrows indicate the typical morphological chpathway was not activated by DCV infection in the early
host-virus interaction and the expression levels of AMPs
from this pathway was down-regulated. And the antiviral
RNAi pathway was not activated by DCV infection in the
early host-virus interaction. Our results indicate that DCV
actively suppresses activation of some immune pathways
in Drosophila cell lines. This work contributes to the un-
derstanding of the early immunologic defense responses
in invertebrate hosts to viral challenge, and it paves the
way for further experiments that investigate the roles of
genes and pathways in antiviral immunity.Materials and methods
Maintenance of Drosophila S2 cell line and treatment
Drosophila S2 cells were cultivated at 28°C in Schneider’s
Drosophila medium (Ivitrogen, USA) supplemented with
10% fetal bovine serum (Gibco, USA). DCV was inocu-
lated in S2 cells at a multiplicity of infection (MOI) of 1
for 4 days and collected for purification as described be-
fore [4]. Then S2 cells were infected with purified DCV
at a multiplicity of infection (MOI) of 1. DCV at a multi-
plicity of infection (MOI) of 1 was UV-inactivated by ex-
posure to a total of 12, 000 mJ UV light (5×3 min) as
inactivated DCV (inDCV), and then S2 cells were inocu-
lated with UV-inactivated DCV. The WSSV were puri-
fied from WSSV-infected shrimp according to the
previous methods [42]. The WSSV virions were UV-
inactivated by exposure to a total of 12, 000 mJ UV light
(5×3 min). Subsequently the inactivated WSSV virions
(1 × 107 copies/mL) were inoculated in S2 cells (1 × 106
cells/mL). After one hour, the S2 cells were collected
and subjected to oligonucleotide microarray.cells. (A) Normal S2 cells, Bar=2 μm. (B) DCV-infected S2 cells at one
fection, Bar=2 μm. (D) Enlarge of one DCV-infected S2 cell at one day
anges of S2 cell caused by DCV infection.
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The total RNA was extracted from treated S2 cells by
using Trizol reagent (Invitrogen, USA) according to the
manufacturer’s instructions. The total RNA samples
were then analyzed by CapitalBio Corp for Drosophila
GeneChip (Affymetrix) assay. And each treatment has 3
biological replicates that were measured by this way. Gene
expression analysis was performed by using the Affymetrix
(Santa Clara, CA, USA) Drosophila GeneChip, using the
laboratory methods in the Affymetrix GeneChip expres-
sion manual. Gene expression analysis was performed
using triple arrays and triple independent mRNA samples
for each treatment. Microarray data were analyzed by
using Bio MAS (molecule annotation system) 3.0 software
(CapitalBio Corporation, Beijing, China). Using the criter-
ion of cutoff limitation as a fold change ≥ 2 or ≤0.5 and q-
value ≤ 5%, differential expression genes were screened
and clustered.Biological pathway analysis
Through array analysis, the commonly altered genes were
screened from DCV, and WSSV treatments. The selected
genes were further analyzed in the context of Gene Ontol-
ogy (GO) biological process and Kyoto Encyclopaedia of
Genes and Genomes (KEGG) biological pathway. Then
the results of signaling pathway and protein interaction
about these genes were analyzed by MAS 3.0 software. To
reveal the functions of predicted target genes, we used the
ontology classification of genes based on gene annotation
and summary information available through DAVID
(Database for Annotation, Visualization and Integrated
Discovery).Transmission electron microscopy assay
The S2 cells were pelleted and fixed in the fixative
containing 2% paraformaldehyde and 2% glutaraldehyde
in 0.1 M sodium cacodylate buffer (pH 7.4) for 18 h at
room temperature. Each sample was washed three times
with 0.1 M sodium cacodylate buffer at room temperature.
Then the sample was postfixed with 2% osmium tetroxide
in 0.1 M sodium cacodylate buffer with constant rotation
for 1h, followed by washes three times using 0.1 M sodium
cacodylate buffer at room temperature. The sample was
stained with 2% uranyl acetate in 0.2 M sodium acetate
buffer (pH 5.2) for 1 h at room temperature and subse-
quently washed three times with 0.2 M sodium acetate
buffer at room temperature. The sample was dehydrated
in an ascending acetone series (50, 60, 70, 80, 90, 95, and
100%) and then in 100% propylene oxide for 10 min with
constant rotation at room temperature. After infiltration
of sample with EMBED 812/Araldite 502 resin at roomtemperature, sections were prepared in a Reichert Ultracut
OMU3 microtome (Leica, Germany) at 100 nm thickness,
followed by staining with 2% uranyl acetate/70% methanol.
The images were collected on a Hitachi 7650 transmission
electron microscope (Hitachi, Japan) operating at 70 kV.
Statistics
Statistical significance was determined by Student's t-test
(two-tailed distribution with a two sample equal variance).
P-values of less than 0.05 were considered significant and
less than 0.01 were considered very significant.
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